Literature DB >> 20851810

Baicalin increases VEGF expression and angiogenesis by activating the ERR{alpha}/PGC-1{alpha} pathway.

Keqiang Zhang1, Jianming Lu, Taisuke Mori, Leslie Smith-Powell, Timothy W Synold, Shiuan Chen, Wei Wen.   

Abstract

AIMS: Baicalin is the major component found in Scutellaria baicalensis root, a widely used herb in traditional Chinese medicine. Although it has been used for thousands of years to treat stroke, the mechanisms of action of S. baicalensis have not been clearly elucidated. In this report, we studied the modulation of angiogenesis as one possible mechanism by investigating the effects of these agents on expression of vascular endothelial growth factor (VEGF), a critical factor for angiogenesis. METHODS AND
RESULTS: The effects of baicalin and an extract of S. baicalensis on VEGF expression were tested in several cell lines. Both agents induced VEGF expression in all cells without increasing expression of hypoxia-inducible factor-1α (HIF-1α). The expression of reporter genes was also activated under the control of the VEGF promoter containing either a functional or a defective HIF response element (HRE). Only minimal effects were observed on reporter activation under the HRE promoter. Instead, both agents significantly induced oestrogen-related receptor (ERRα) expression as well as the activity of reporter genes under the control of ERRα-binding element. Their ability to induce VEGF expression was suppressed once ERRα expression was knocked down by siRNA or ERRα-binding sites were deleted in the VEGF promoter. We also found that both agents stimulated cell migration and vessel sprout formation from the aorta.
CONCLUSION: Our results implicate baicalin and S. baicalensis in angiogenesis by inducing VEGF expression through the activation of the ERRα pathway. These data may facilitate a better understanding of the potential health benefits of these agents in the treatment of cardiovascular diseases.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20851810      PMCID: PMC3020130          DOI: 10.1093/cvr/cvq296

Source DB:  PubMed          Journal:  Cardiovasc Res        ISSN: 0008-6363            Impact factor:   10.787


  49 in total

1.  Critical role for NF-kappaB-induced JunB in VEGF regulation and tumor angiogenesis.

Authors:  Dirk Schmidt; Björn Textor; Oliver T Pein; Alexander H Licht; Sven Andrecht; Melanie Sator-Schmitt; Norbert E Fusenig; Peter Angel; Marina Schorpp-Kistner
Journal:  EMBO J       Date:  2007-01-25       Impact factor: 11.598

2.  Engineering vascularized tissues using natural and synthetic small molecules.

Authors:  Lauren S Sefcik; Caren E Petrie Aronin; Edward A Botchwey
Journal:  Organogenesis       Date:  2008-10       Impact factor: 2.500

Review 3.  Patterns and emerging mechanisms of the angiogenic switch during tumorigenesis.

Authors:  D Hanahan; J Folkman
Journal:  Cell       Date:  1996-08-09       Impact factor: 41.582

4.  Quercetin activates an angiogenic pathway, hypoxia inducible factor (HIF)-1-vascular endothelial growth factor, by inhibiting HIF-prolyl hydroxylase: a structural analysis of quercetin for inhibiting HIF-prolyl hydroxylase.

Authors:  Hyunchu Jeon; Heejung Kim; Daekyu Choi; Duksoo Kim; Shi-Young Park; Yung-Jin Kim; Young Mi Kim; Yunjin Jung
Journal:  Mol Pharmacol       Date:  2007-03-21       Impact factor: 4.436

Review 5.  Dietary flavonoids: effects on xenobiotic and carcinogen metabolism.

Authors:  Young Jin Moon; Xiaodong Wang; Marilyn E Morris
Journal:  Toxicol In Vitro       Date:  2005-11-11       Impact factor: 3.500

6.  The coactivator PGC-1 cooperates with peroxisome proliferator-activated receptor alpha in transcriptional control of nuclear genes encoding mitochondrial fatty acid oxidation enzymes.

Authors:  R B Vega; J M Huss; D P Kelly
Journal:  Mol Cell Biol       Date:  2000-03       Impact factor: 4.272

7.  Green tea inhibits vascular endothelial growth factor (VEGF) induction in human breast cancer cells.

Authors:  Maryam R Sartippour; Zhi-Ming Shao; David Heber; Perrin Beatty; Liping Zhang; Canhui Liu; Lee Ellis; Wen Liu; Vay Liang Go; Mai N Brooks
Journal:  J Nutr       Date:  2002-08       Impact factor: 4.798

8.  The VIVA trial: Vascular endothelial growth factor in Ischemia for Vascular Angiogenesis.

Authors:  Timothy D Henry; Brian H Annex; George R McKendall; Michael A Azrin; John J Lopez; Frank J Giordano; P K Shah; James T Willerson; Raymond L Benza; Daniel S Berman; C Michael Gibson; Alex Bajamonde; Amy Chen Rundle; Jennifer Fine; Edward R McCluskey
Journal:  Circulation       Date:  2003-03-18       Impact factor: 29.690

9.  Flavone and isoflavone phytoestrogens are agonists of estrogen-related receptors.

Authors:  Masatomo Suetsugi; Leila Su; Kimberly Karlsberg; Yate-Ching Yuan; Shiuan Chen
Journal:  Mol Cancer Res       Date:  2003-11       Impact factor: 5.852

Review 10.  Angiogenesis in cancer, vascular, rheumatoid and other disease.

Authors:  J Folkman
Journal:  Nat Med       Date:  1995-01       Impact factor: 53.440

View more
  35 in total

1.  Striated muscle activator of Rho signalling (STARS) is a PGC-1α/oestrogen-related receptor-α target gene and is upregulated in human skeletal muscle after endurance exercise.

Authors:  Marita A Wallace; M Benjamin Hock; Bethany C Hazen; Anastasia Kralli; Rod J Snow; Aaron P Russell
Journal:  J Physiol       Date:  2011-02-21       Impact factor: 5.182

2.  Kaempferol targets estrogen-related receptor α and suppresses the angiogenesis of human retinal endothelial cells under high glucose conditions.

Authors:  Yan Wu; Qinmei Zhang; Rui Zhang
Journal:  Exp Ther Med       Date:  2017-10-03       Impact factor: 2.447

3.  Peroxisome proliferator-activated receptor γ co-activator 1-α as a critical co-activator of the murine hepatic oxidative stress response and mitochondrial biogenesis in Staphylococcus aureus sepsis.

Authors:  Anne D Cherry; Hagir B Suliman; Raquel R Bartz; Claude A Piantadosi
Journal:  J Biol Chem       Date:  2013-11-19       Impact factor: 5.157

4.  Variation of pathways and network profiles reveals the differential pharmacological mechanisms of each effective component to treat middle cerebral artery ischemia-reperfusion mice.

Authors:  HaiXia Dang; KangNing Li; YaNan Yu; YingYing Zhang; Jun Liu; PengQian Wang; Bing Li; HaiNan Wang; Haixia Li; Zhong Wang; YongYan Wang
Journal:  Exp Biol Med (Maywood)       Date:  2015-07-12

5.  ERRα coordinates actin and focal adhesion dynamics.

Authors:  Violaine Tribollet; Catherine Cerutti; Alain Géloën; Emmanuelle Berger; Richard De Mets; Martial Balland; Julien Courchet; Jean-Marc Vanacker; Christelle Forcet
Journal:  Cancer Gene Ther       Date:  2022-04-04       Impact factor: 5.854

Review 6.  Therapeutic angiogenesis-based strategy for peripheral artery disease.

Authors:  Jingxuan Han; Lailiu Luo; Olivia Marcelina; Vivi Kasim; Shourong Wu
Journal:  Theranostics       Date:  2022-06-27       Impact factor: 11.600

Review 7.  Exercise training and peripheral arterial disease.

Authors:  Tara L Haas; Pamela G Lloyd; Hsiao-Tung Yang; Ronald L Terjung
Journal:  Compr Physiol       Date:  2012-10       Impact factor: 9.090

8.  Pharmacological Development of Target-Specific Delocalized Lipophilic Cation-Functionalized Carboranes for Cancer Therapy.

Authors:  Eirini D Tseligka; Aikaterini Rova; Elsa P Amanatiadou; Gianpiero Calabrese; John Tsibouklis; Dimitrios G Fatouros; Ioannis S Vizirianakis
Journal:  Pharm Res       Date:  2016-04-26       Impact factor: 4.200

9.  G9a Promotes Invasion and Metastasis of Non-Small Cell Lung Cancer through Enhancing Focal Adhesion Kinase Activation via NF-κB Signaling Pathway.

Authors:  Ting Sun; Keqiang Zhang; Rajendra P Pangeni; Jun Wu; Wendong Li; Yong Du; Yuming Guo; Shyambabu Chaurasiya; Leonidas Arvanitis; Dan J Raz
Journal:  Mol Cancer Res       Date:  2020-12-09       Impact factor: 5.852

10.  Inhibitory effect of baicalin and baicalein on ovarian cancer cells.

Authors:  Jianchu Chen; Zhaoliang Li; Allen Y Chen; Xingqian Ye; Haitao Luo; Gary O Rankin; Yi Charlie Chen
Journal:  Int J Mol Sci       Date:  2013-03-15       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.